Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries (vol 39, pg 3735, 2022)

被引：1
|
作者：
Fulcher, Gregory R. [1 ]
Akhtar, Shahid [2 ]
Al-Jaser, Saleh J. [3 ]
Medina, Johan [4 ]
Mohamed, Mafauzy [5 ]
Nicodemus, Nemencio A., Jr. [6 ]
Olsen, Anne Helene [4 ]
Singh, Kiran P. [7 ]
Kok, Adri [8 ,9 ]
机构：
[1] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[2] Novo Nordisk Reg Asia Pacific, Dubai, U Arab Emirates
[3] Specialized Med Ctr Hosp, Dept Internal Med, Riyadh, Saudi Arabia
[4] Novo Nordisk AS, Soborg, Denmark
[5] Hosp Univ Sains Malaysia, Dept Med, Kota Baharu, Kelantan, Malaysia
[6] Univ Philippines, Coll Med, Dept Biochem & Mol Biol, Manila, Philippines
[7] Fortis Hosp, Dept Endocrinol, Mohali, Punjab, India
[8] Netcare Union & Clinton Hosp, Alberton, South Africa
[9] Univ Witwatersrand, Johannesburg, South Africa
来源：
ADVANCES IN THERAPY | 2023年 / 40卷 / 01期
关键词：
D O I：
10.1007/s12325-022-02349-1
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [41] iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study
    Lajara, Rosemarie
    Heller, Caroline
    Pantalone, Kevin M.
    Lew, Elisheva
    Li, Xuan
    Dex, Terry
    Kilpatrick, Catherine Rachel
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1249 - 1260
  • [42] Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naive people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England
    Davies, Melanie J.
    Alibegovic, Amra Ciric
    Jensen, Anders Boeck
    Munikrishnappa, Renuka
    Nordsborg, Rikke Baastrup
    Braae, Uffe Christian
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2756 - 2764
  • [43] A Real-World, Prospective, Non-interventional Study of Adults with T2D Switching to IDegAsp from Glargine U100 or U300 in Japan
    Shigiyama, Fumika
    Liu, Lei
    Nordahl, Helene
    Suzuki, Ryo
    Yamamoto, Yuiko
    Hirose, Takahisa
    [J]. DIABETES THERAPY, 2021, 12 (09) : 2405 - 2421
  • [44] A Real-World, Prospective, Non-interventional Study of Adults with T2D Switching to IDegAsp from Glargine U100 or U300 in Japan
    Fumika Shigiyama
    Lei Liu
    Helene Nordahl
    Ryo Suzuki
    Yuiko Yamamoto
    Takahisa Hirose
    [J]. Diabetes Therapy, 2021, 12 : 2405 - 2421
  • [45] Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real-world, multicentre study
    Donaldson, Laura E.
    Fourlanos, Spiros
    Vogrin, Sara
    MacIsaac, Richard J.
    Colman, Peter G.
    McAuley, Sybil A.
    [J]. INTERNAL MEDICINE JOURNAL, 2024, 54 (01) : 121 - 128
  • [46] Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient-Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study
    Cornford, Philip
    Jefferson, Kieran
    Cole, Owen
    Gilbody, John
    [J]. ONCOLOGY AND THERAPY, 2018, 6 (02) : 173 - 187
  • [47] Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Nave Type 2 Diabetes Adults: RESTORE-2 Real-World Study
    Fadini, Gian Paolo
    Buzzetti, Raffaella
    Nicolucci, Antonio
    Rossi, Maria Chiara
    Larosa, Monica
    Cucinotta, Domenico
    [J]. DIABETES, 2021, 70
  • [48] Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study
    Sándor Szépkúti
    Szilvia Bandur
    Gábor Kovács
    Tamás Ferenci
    Márk M. Svébis
    Piroska Turbucz
    Ádám G. Tabák
    [J]. BMC Endocrine Disorders, 22
  • [49] Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study
    Szepkuti, Sandor
    Bandur, Szilvia
    Kovacs, Gabor
    Ferenci, Tamas
    Svebis, Mark M.
    Turbucz, Piroska
    Tabak, Adam G.
    [J]. BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [50] Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage (vol 12, pg 1225, 2019)
    Wilke, T.
    Picker, N.
    Mueller, S.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1397 - 1397
12345